Adherence to alendronate in male veterans (Q36953237)

17 August 2017

Adherence to alendronate in male veterans (English)

1 reference

17 August 2017

0 references

Hansen KE

1

1 reference

17 August 2017

Swenson ED

2

1 reference

17 August 2017

Baltz B

3

1 reference

17 August 2017

Schuna AA

4

1 reference

17 August 2017

Jones AN

5

1 reference

17 August 2017

Elliott ME

6

1 reference

17 August 2017

language of work or name

English

0 references

publication date

26 September 2007

1 reference

Osteoporosis International

17 August 2017

1 reference

17 August 2017

19

1 reference

17 August 2017

3

1 reference

17 August 2017

349-356

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-007-0471-4

17 August 2017

0 references

cites work

Severe osteoporosis in men.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-007-0471-4

A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-007-0471-4

Compliance with pharmacologic therapy for osteoporosis

21 January 2018

1 reference

12 December 2020

Compliance with osteoporosis medications

1 reference

12 December 2020

How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy

1 reference

12 December 2020

Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study

1 reference

12 December 2020

Patient factors and medication guideline adherence among older women with asthma

1 reference

12 December 2020

Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting.

1 reference

12 December 2020

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.

1 reference

12 December 2020

Compliance with osteoporosis therapy is the weakest link

1 reference

12 December 2020

Effects of computer generated reminder charts on patients' compliance with drug regimens

1 reference

12 December 2020

Alendronate for the Treatment of Osteoporosis in Men

1 reference

12 December 2020

Compliance with drug therapies for the treatment and prevention of osteoporosis

1 reference

12 December 2020

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

1 reference

12 December 2020

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

1 reference

12 December 2020

Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users.

1 reference

12 December 2020

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

1 reference

12 December 2020

The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial

1 reference

12 December 2020

Assessment of compliance with osteoporosis treatment and its consequences in a managed care population

1 reference

12 December 2020

Adherence to Medication

1 reference

12 December 2020

Persistence with weekly alendronate therapy among postmenopausal women

1 reference

12 December 2020

Compliance with drug therapy for postmenopausal osteoporosis

1 reference

12 December 2020

Secondary causes of osteoporosis in men.

1 reference

12 December 2020

The impact of smoking on adherence to treatment for latent tuberculosis infection

1 reference

12 December 2020

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

1 reference

12 December 2020

Determinants of adherence to osteoporosis treatment in clinical practice

1 reference

12 December 2020

Pharmacoepidemiology and rheumatic diseases: 2001-2002.

1 reference

12 December 2020

Factors associated with drug adherence and blood pressure control in patients with hypertension

1 reference

12 December 2020

The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis

1 reference

12 December 2020

Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey

1 reference

12 December 2020

Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial

1 reference

12 December 2020

1 reference

12 December 2020

Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults

1 reference

12 December 2020

Osteoporosis prevention, diagnosis, and therapy

1 reference

12 December 2020

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

1 reference

12 December 2020

Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence

1 reference

12 December 2020

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

1 reference

12 December 2020

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

12 December 2020

Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women

1 reference

12 December 2020

Burden of major musculoskeletal conditions.

1 reference

12 December 2020

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension

1 reference

12 December 2020

10.1007/S00198-007-0471-4

Identifiers

DOI

1 reference

17 August 2017

1 reference